OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 72 filers reported holding OCULAR THERAPEUTIX INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $733 | +19.4% | 233,582 | +96.4% | 0.06% | +3.3% |
| Q2 2023 | $614 | -99.9% | 118,953 | -7.1% | 0.06% | -20.8% |
| Q2 2022 | $514,000 | +80.4% | 127,978 | +122.1% | 0.08% | +102.6% |
| Q1 2022 | $285,000 | +738.2% | 57,620 | +413.5% | 0.04% | +660.0% |
| Q3 2019 | $34,000 | -66.7% | 11,222 | -28.1% | 0.01% | 0.0% |
| Q1 2018 | $102,000 | -60.9% | 15,600 | +25.7% | 0.01% | -50.0% |
| Q2 2015 | $261,000 | – | 12,412 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |